Cryo Cell International (CCEL) Cash from Investing Activities (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Cash from Investing Activities data on file, last reported at $19104.0 in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at $19104.0, up 106.65% year-over-year; the trailing twelve-month figure through Feb 2026 was -$668744.0 (up 86.14% YoY), and the FY2025 annual result was -$975332.0, up 80.0% from the prior year.
• Cash from Investing Activities grew to $19104.0 in Q1 2026 per CCEL's latest filing, from -$289649.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $1.9 million in Q4 2022 and troughed at -$11.2 million in Q3 2022.
• A 5-year average of -$1.7 million and a median of -$1.1 million in 2024 frame the typical range for Cash from Investing Activities.
• On a YoY basis, Cash from Investing Activities climbed as much as 758.4% in 2022 and fell as far as 3637.07% in 2022.
• A 5-year view of Cash from Investing Activities shows it stood at $1.9 million in 2022, then sank by 203.45% to -$2.0 million in 2023, then soared by 43.7% to -$1.1 million in 2024, then surged by 74.04% to -$289649.0 in 2025, then jumped by 106.6% to $19104.0 in 2026.
• Business Quant data shows CCEL's Cash from Investing Activities at $19104.0 in Q1 2026, -$289649.0 in Q4 2025, and $1.1 million in Q3 2025.